个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Comparison of efficacy and safety of paclitaxel and capecitabine followed by capecitabine as maintenance therapy versus cisplatin and capecitabine therapy for advanced gastric cancer: a multicentre, randomised, active-controlled phase III study

| 导出 |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：
X. Zhang[1] * ; L. Shen[1] ; Z. Lu[1] ; W. Liu[2] ; T. Liu[3] ; B. Hu[4] ; W. Li[5] ; Q. Fan[6] ; J. Xu[7] ; N. Xu[8] ; Y. Bai[9] ; Y. Pan[10] ; Q. Xu[11] ; W. Bai[12] ; L. Xia[13] ; Y. Gao[14] ; W. Wang[15] ; Y. Shu[16] ; G. Dai[17] ; J. Feng[18] ;
机构： [1]Department of GI Oncology, Peking University School of Oncology, BeijingCancer Hospital and Institute, Laboratory of Carcinogenesis and TranslationalResearch (Ministry of Education), Beijing, China [2]Oncology, 4th Hospital Hebei Medical University, Shijiazhuang, China [3]Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China [4]Oncology, Anhui Provincial Hospital, Hefei, China [5]Oncology, 1st Hospital of Jilin University, Changchun, China [6]Oncology, 1st Affiliated Hospital of Zhengzhou University, Zhengzhou, China [7]Oncology, 307th Hospital of PLA (AMMS China), Beijing, China [8]Oncology, 1st Affiliated Hospital of Zhejiang University School of Medicine,Hangzhou, China [9]Medical Oncology, Cancer Hospital Affiliated to Harbin Medical University,,Harbin, China [10]Medical Oncology, The First Affiliated Hospital of Medical University of Anhui,Hefei, China [11]Oncology, 10th People’s Hospital of Shanghai, Tongji University, Shanghai,China [12]Gastrointestinal, Shanxi Tumor Hospital, Taiyuan, China [13]Oncology, People’s Hospital of Jilin Province, Changchun, China [14]Oncology, Shanghai East hospital, Tongji University, Shanghai, China [15]Gastrointestinal, Guizhou Cancer Hospital, Guizhou, China [16]Oncology, Jiangsu Provincial People’s Hospital (The First Affiliated Hospital ofNanjing Medical University), Nanjing, China [17]Oncology, Air Force General Hospital (PLA), Beijing, China [18]Gastrointestinal, Jiangsu Cancer Institute and Hospital, Nanjing, China
出处：
ISSN：
语种：
外文
被引次数：
WOS：
中科院分区：
出版当年[2015]版：
大类 | 1 区 医学
小类 | 2 区 肿瘤学
最新[2025]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
JCR分区：
出版当年[2015]版：
Q1 ONCOLOGY
最新[2024]版：
Q1 ONCOLOGY

影响因子： 最新[2024版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者：
第一作者机构： [1]Department of GI Oncology, Peking University School of Oncology, BeijingCancer Hospital and Institute, Laboratory of Carcinogenesis and TranslationalResearch (Ministry of Education), Beijing, China
推荐引用方式(GB/T 7714)：
X. Zhang,L. Shen,Z. Lu,et al.Comparison of efficacy and safety of paclitaxel and capecitabine followed by capecitabine as maintenance therapy versus cisplatin and capecitabine therapy for advanced gastric cancer: a multicentre, randomised, active-controlled phase III study[J].ANNALS OF ONCOLOGY.2015,26:44-44.
APA：
X. Zhang,L. Shen,Z. Lu,W. Liu,T. Liu...&J. Feng.(2015).Comparison of efficacy and safety of paclitaxel and capecitabine followed by capecitabine as maintenance therapy versus cisplatin and capecitabine therapy for advanced gastric cancer: a multicentre, randomised, active-controlled phase III study.ANNALS OF ONCOLOGY,26,
MLA：
X. Zhang,et al."Comparison of efficacy and safety of paclitaxel and capecitabine followed by capecitabine as maintenance therapy versus cisplatin and capecitabine therapy for advanced gastric cancer: a multicentre, randomised, active-controlled phase III study".ANNALS OF ONCOLOGY 26.(2015):44-44

资源点击量：42329 今日访问量：0 总访问量：1365 更新日期：2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持：重庆聚合科技有限公司 地址：河北省石家庄市健康路12号